Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 146

1.

Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?

Posch F, Leitner L, Bergovec M, Bezan A, Stotz M, Gerger A, Pichler M, Stöger H, Liegl-Atzwanger B, Leithner A, Szkandera J.

Clin Orthop Relat Res. 2017 Jan 12. doi: 10.1007/s11999-017-5232-x. [Epub ahead of print]

PMID:
28083752
2.

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.

Pehserl AM, Ress AL, Stanzer S, Resel M, Karbiener M, Stadelmeyer E, Stiegelbauer V, Gerger A, Mayr C, Scheideler M, Hutterer GC, Bauernhofer T, Kiesslich T, Pichler M.

Int J Mol Sci. 2016 Dec 1;17(12). pii: E2011.

3.

Serum sclerostin levels in renal cell carcinoma patients with bone metastases.

Wibmer C, Amrein K, Fahrleitner-Pammer A, Gilg MM, Berghold A, Hutterer GC, Maurer-Ertl W, Gerger A, Leithner A, Pichler M, Szkandera J.

Sci Rep. 2016 Sep 26;6:33551. doi: 10.1038/srep33551.

4.

Current Status of Long Non-Coding RNAs in Human Breast Cancer.

Cerk S, Schwarzenbacher D, Adiprasito JB, Stotz M, Hutterer GC, Gerger A, Ling H, Calin GA, Pichler M.

Int J Mol Sci. 2016 Sep 6;17(9). pii: E1485. doi: 10.3390/ijms17091485. Review.

5.

Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.

Pichler M, Stiegelbauer V, Vychytilova-Faltejskova P, Ivan C, Ling H, Winter E, Zhang X, Goblirsch M, Wulf-Goldenberg A, Ohtsuka M, Haybaeck J, Svoboda M, Okugawa Y, Gerger A, Hoefler G, Goel A, Slaby O, Calin GA.

Clin Cancer Res. 2016 Sep 6. doi: 10.1158/1078-0432.CCR-16-0497. [Epub ahead of print]

PMID:
27601590
6.

Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection.

Stotz M, Liegl-Atzwanger B, Posch F, Mrsic E, Thalhammer M, Stojakovic T, Bezan A, Pichler M, Gerger A, Szkandera J.

PLoS One. 2016 Jul 25;11(7):e0159448. doi: 10.1371/journal.pone.0159448.

7.

The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients.

Rief P, Pichler M, Raggam R, Hafner F, Gerger A, Eller P, Brodmann M, Gary T.

Medicine (Baltimore). 2016 Jun;95(24):e3843. doi: 10.1097/MD.0000000000003843.

8.

The width of resection margins influences local recurrence in soft tissue sarcoma patients.

Kainhofer V, Smolle MA, Szkandera J, Liegl-Atzwanger B, Maurer-Ertl W, Gerger A, Riedl J, Leithner A.

Eur J Surg Oncol. 2016 Jun;42(6):899-906. doi: 10.1016/j.ejso.2016.03.026.

PMID:
27107792
9.

Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma.

Seles M, Hutterer GC, Kiesslich T, Pummer K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger A, Pichler M.

Int J Mol Sci. 2016 Apr 15;17(4):573. doi: 10.3390/ijms17040573. Review.

10.

An observational study identifying obese subgroups among older adults at increased risk of mobility disability: do perceptions of the neighborhood environment matter?

King AC, Salvo D, Banda JA, Ahn DK, Gill TM, Miller M, Newman AB, Fielding RA, Siordia C, Moore S, Folta S, Spring B, Manini T, Pahor M; LIFE Study Investigators..

Int J Behav Nutr Phys Act. 2015 Dec 18;12:157. doi: 10.1186/s12966-015-0322-1.

11.

Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.

Stotz M, Gerger A, Haybaeck J, Kiesslich T, Bullock MD, Pichler M.

Anticancer Res. 2015 Nov;35(11):5737-44. Review.

PMID:
26503994
12.

An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.

Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T.

Breast. 2015 Oct;24(5):667-72. doi: 10.1016/j.breast.2015.08.003.

PMID:
26346586
13.

Effect of a 24-Month Physical Activity Intervention vs Health Education on Cognitive Outcomes in Sedentary Older Adults: The LIFE Randomized Trial.

Sink KM, Espeland MA, Castro CM, Church T, Cohen R, Dodson JA, Guralnik J, Hendrie HC, Jennings J, Katula J, Lopez OL, McDermott MM, Pahor M, Reid KF, Rushing J, Verghese J, Rapp S, Williamson JD; LIFE Study Investigators..

JAMA. 2015 Aug 25;314(8):781-90. doi: 10.1001/jama.2015.9617.

14.

Genetic markers of recurrence in colorectal cancer.

Smolle MA, Pichler M, Haybaeck J, Gerger A.

Pharmacogenomics. 2015;16(11):1315-28. doi: 10.2217/pgs.15.83. Review.

PMID:
26266878
15.

The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.

Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T.

Tumour Biol. 2016 Jan;37(1):361-8. doi: 10.1007/s13277-015-3805-4.

PMID:
26219894
16.

Vitamin D and prostate cancer prognosis: a Mendelian randomization study.

Trummer O, Langsenlehner U, Krenn-Pilko S, Pieber TR, Obermayer-Pietsch B, Gerger A, Renner W, Langsenlehner T.

World J Urol. 2016 Apr;34(4):607-11. doi: 10.1007/s00345-015-1646-9.

PMID:
26209090
17.

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group..

Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3.

PMID:
26040499
18.

Low spinophilin expression enhances aggressive biological behavior of breast cancer.

Schwarzenbacher D, Stiegelbauer V, Deutsch A, Ress AL, Aigelsreiter A, Schauer S, Wagner K, Langsenlehner T, Resel M, Gerger A, Ling H, Ivan C, Calin GA, Hoefler G, Rinner B, Pichler M.

Oncotarget. 2015 May 10;6(13):11191-202.

19.

Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy.

Langsenlehner T, Pichler M, Thurner EM, Krenn-Pilko S, Stojakovic T, Gerger A, Langsenlehner U.

Urol Oncol. 2015 May;33(5):201.e9-16. doi: 10.1016/j.urolonc.2015.02.002.

PMID:
25769845
20.

Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.

Reitz D, Gerger A, Seidel J, Kornprat P, Samonigg H, Stotz M, Szkandera J, Pichler M.

J Clin Pathol. 2015 Jun;68(6):427-33. doi: 10.1136/jclinpath-2014-202451. Erratum in: J Clin Pathol. 2015 Jul;68(7):e2.

PMID:
25759406
Items per page

Supplemental Content

Loading ...
Support Center